242
Views
57
CrossRef citations to date
0
Altmetric
Drug Profile

Samarium lexidronam (153Sm-EDTMP): skeletal radiation for osteoblastic bone metastases and osteosarcoma

&
Pages 1517-1527 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Hesham M. H. Zakaly, Mostafa Y. A. Mostafa, Darya Deryabina & Michael Zhukovsky. (2020) Comparative studies on the potential use of 177Lu-based radiopharmaceuticals for the palliative therapy of bone metastases. International Journal of Radiation Biology 96:6, pages 779-789.
Read now
Natasha Ali, Bushra Moiz, Hira Silat, Anam Rehan & Salman Adil. (2013) Improved outcome of myeloma related bone pain with oral analgesics and bisphosphonate therapy: A single-center experience from Pakistan. Progress in Palliative Care 21:6, pages 337-340.
Read now
Costantino Errani, Alessandra Longhi, Giuseppe Rossi, Eugenio Rimondi, Alessio Biazzo, Angelo Toscano, Nikolin Alì, Pietro Ruggieri, Marco Alberghini, Piero Picci, Gaetano Bacci & Mario Mercuri. (2011) Palliative therapy for osteosarcoma. Expert Review of Anticancer Therapy 11:2, pages 217-227.
Read now
Dennis PM Hughes. (2009) Strategies for the targeted delivery of therapeutics for osteosarcoma. Expert Opinion on Drug Delivery 6:12, pages 1311-1321.
Read now
Pete Anderson, Lisa Kopp, Nicholas Anderson, Kathleen Cornelius, Cynthia Herzog, Dennis Hughes & Winston Huh. (2008) Novel bone cancer drugs: investigational agents and control paradigms for primary bone sarcomas (Ewing's sarcoma and osteosarcoma). Expert Opinion on Investigational Drugs 17:11, pages 1703-1715.
Read now
Elisabetta Abruzzese, Francesco Iuliano, Malgorzata Monika Trawinska & Massimo Di Maio. (2008) 153Sm: its use in multiple myeloma and report of a clinical experience. Expert Opinion on Investigational Drugs 17:9, pages 1379-1387.
Read now

Articles from other publishers (51)

Fen Jiao, Wei Li, Xu Wang, Congren Yang, Zhengquan Zhang, Liwen Fu & Wenqing Qin. (2023) Application of EDTMPS as a novel calcite depressant in scheelite flotation. International Journal of Mining Science and Technology 33:5, pages 639-647.
Crossref
Alec B Landau, Vivian S Zhu, Akshay J Reddy, Chetan Yarlagadda, Matthew Corsi, Levi M Travis, Mohamed Abutineh, Ali Idriss & Rakesh Patel. (2023) Exploring the Role of External Beam Radiation Therapy in Osteosarcoma Treatment: Impact of Diagnostic Imaging Delays and Innovative Techniques. Cureus.
Crossref
V. K. Tishchenko, V. M. Petriev, A. V. Matveev, A. V. Fedorova & K. A. Kuzenkova. (2022) Biodistribution of Osteotropic 177Lu-EDTMP – a Potential Radiopharmaceutical for Radionuclide Therapy of Bone Metastases. Pharmaceutical Chemistry Journal 56:7, pages 883-888.
Crossref
Alexander W. E. Sadler, Leena Hogan, Benjamin Fraser & Louis M. Rendina. (2022) Cutting edge rare earth radiometals: prospects for cancer theranostics. EJNMMI Radiopharmacy and Chemistry 7:1.
Crossref
Partha S. Choudhury & Manoj Gupta. 2022. Nuclear Medicine and Molecular Imaging. Nuclear Medicine and Molecular Imaging 249 252 .
Viviana Frantellizzi, Melissa Montebello, Ferdinando Corica & Giuseppe De Vincentis. 2022. Nuclear Medicine and Molecular Imaging. Nuclear Medicine and Molecular Imaging 233 240 .
Suna Kıraç. 2022. Radionuclide Therapy. Radionuclide Therapy 29 62 .
George Sgouros, Wesley E. Bolch, Arturo Chiti, Yuni K. Dewaraja, Dimitris Emfietzoglou, Robert F. Hobbs, Mark Konijnenberg, Katarina Sjögreen-Gleisner, Lidia Strigari, Tzu-Chen Yen & Roger W. Howell. (2022) ICRU REPORT 96, Dosimetry-Guided Radiopharmaceutical Therapy. Journal of the ICRU 21:1, pages 1-212.
Crossref
Fatemeh Naseri, Seyed. Ali Faal Rastegar, Nafise Salek, Amir charkhi & Ali yadollahi. (2021) Effective isolation of europium impurities from 153Sm using electro amalgamation approach based on response surface methodology. Separation and Purification Technology 279, pages 119701.
Crossref
Fatemeh Naseri, Amir Charkhi, Nafise Salek & Sara Vosoughi. (2021) The radio-europium impurities in [153Sm]-EDTMP production: a review of isolation methods. Nuclear Medicine Communications 42:9, pages 951-963.
Crossref
Emran AskariSara HarsiniNasim VahidfarGhasemali DivbandRamin Sadeghi. (2021) 177 Lu-EDTMP for Metastatic Bone Pain Palliation: A Systematic Review and Meta-Analysis . Cancer Biotherapy and Radiopharmaceuticals 36:5, pages 383-390.
Crossref
Hun Yee Tan, Chai Hong Yeong, Yin How Wong, Molly McKenzie, Azahari Kasbollah, Mohamad Nazri Md. Shah & Alan Christopher Perkins. (2020) Neutron-activated theranostic radionuclides for nuclear medicine. Nuclear Medicine and Biology 90-91, pages 55-68.
Crossref
Hesham MH Zakaly, Mostafa Y. A. Mostafa & M Zhukovsky. (2020) Labeling of ethylenediamine tetramethylene phosphonate with 153Sm and 177Lu,Comparison Study. Asia-Pacific Journal of Oncology, pages 1-7.
Crossref
Sudipta Chakraborty, Priyalata Shetty, Rubel Chakravarty, K. V. Vimalnath, Chandan Kumar, H. D. Sarma, Rakhee Vatsa, Jaya Shukla, B. R. Mittal & Ashutosh Dash. (2020) Formulation of ‘ready-to-use’ human clinical doses of 177 Lu-labeled bisphosphonate amide of DOTA using moderate specific activity 177 Lu and its preliminary evaluation in human patient . Radiochimica Acta 108:8, pages 661-672.
Crossref
Reyhaneh Manafi-Farid, Fardad Masoumi, Ghasemali Divband, Bahare Saidi, Bahar Ataeinia, Fabian Hertel, Gregor Schweighofer-Zwink, Agnieszka Morgenroth & Mohsen Beheshti. (2020) Targeted Palliative Radionuclide Therapy for Metastatic Bone Pain. Journal of Clinical Medicine 9:8, pages 2622.
Crossref
Ashutosh Dash, Tapas Das & Furn F. Russ Knapp. (2020) Targeted Radionuclide Therapy of Painful Bone Metastases: Past Developments, Current Status, Recent Advances and Future Directions. Current Medicinal Chemistry 27:19, pages 3187-3249.
Crossref
Michiel Van de Voorde, Karen Van Hecke, Koen Binnemans & Thomas Cardinaels. (2020) Supported ionic liquid phases for the separation of samarium and europium in nitrate media: Towards purification of medical samarium-153. Separation and Purification Technology 232, pages 115939.
Crossref
Peter M. Anderson. 2020. Current Advances in Osteosarcoma. Current Advances in Osteosarcoma 45 53 .
Vivek Subbiah, Pete M. Anderson, Kalevi Kairemo, Kenneth Hess, Winston W. Huh, Vinod Ravi, Najat C. Daw, Neeta Somaiah, Joseph A. Ludwig, Robert S. Benjamin, Sant Chawla, David S. Hong, Funda Meric-Bernstam, Gregory Ravizzini, Eugenie Kleinerman, Homer Macapinlac & Eric Rohren. (2019) Alpha Particle Radium 223 Dichloride in High-risk Osteosarcoma: A Phase I Dose Escalation Trial. Clinical Cancer Research 25:13, pages 3802-3810.
Crossref
Michiel Van de Voorde, Karen Van Hecke, Thomas Cardinaels & Koen Binnemans. (2019) Radiochemical processing of nuclear-reactor-produced radiolanthanides for medical applications. Coordination Chemistry Reviews 382, pages 103-125.
Crossref
Nafise Salek, Simindokht Shirvani Arani, Ali Bahrami Samani, Sara Vosoghi & Mohsen Mehrabi. (2017) Feasibility study for production and quality control of Yb-175 as a byproduct of no carrier added Lu-177 preparation for radiolabeling of DOTMP. Australasian Physical & Engineering Sciences in Medicine 41:1, pages 69-79.
Crossref
Dana C. Baiu, Ian R. Marsh, Alexander E. Boruch, Ankita Shahi, Saswati Bhattacharya, Justin J. Jeffery, Qianqian Zhao, Lance T. Hall, Jamey P. Weichert, Bryan P. Bednarz & Mario Otto. (2018) Targeted Molecular Radiotherapy of Pediatric Solid Tumors Using a Radioiodinated Alkyl-Phospholipid Ether Analog. Journal of Nuclear Medicine 59:2, pages 244-250.
Crossref
Michiel Van de Voorde, Karen Van Hecke, Koen Binnemans & Thomas Cardinaels. (2018) Separation of samarium and europium by solvent extraction with an undiluted quaternary ammonium ionic liquid: towards high-purity medical samarium-153. RSC Advances 8:36, pages 20077-20086.
Crossref
Angelo J. Amoroso, Ian A. Fallis & Simon J.A. Pope. (2017) Chelating agents for radiolanthanides: Applications to imaging and therapy. Coordination Chemistry Reviews 340, pages 198-219.
Crossref
Nafise Salek, Mojtaba Shamsaei, Mohammad Ghannadi Maragheh, Simindokht Shirvani Arani & Ali Bahrami Samani. (2016) Production and quality control 177 Lu (NCA)-DOTMP as a potential agent for bone pain palliation . Journal of Applied Clinical Medical Physics 17:6, pages 128-139.
Crossref
Philip J. Blower. (2015) A nuclear chocolate box: the periodic table of nuclear medicine. Dalton Trans. 44:11, pages 4819-4844.
Crossref
Hassan Ranjbar, Ali Bahrami-Samani, Davood Beiki, Simindokht Shirvani-Arani & Mohammad Ghannadi-Maragheh. (2014) Evaluation of 153Sm/177Lu-EDTMP mixture in wild-type rodents as a novel combined palliative treatment of bone pain agent. Journal of Radioanalytical and Nuclear Chemistry 303:1, pages 71-79.
Crossref
Ashley Sekhon, Karl Haglund & Michael Guiou. 2015. Malignant Pediatric Bone Tumors - Treatment & Management. Malignant Pediatric Bone Tumors - Treatment & Management 109 124 .
Joanne Lagmay & Nicholas D. Yeager. 2015. Malignant Pediatric Bone Tumors - Treatment & Management. Malignant Pediatric Bone Tumors - Treatment & Management 221 263 .
Chai-Hong Yeong, Mu-hua Cheng & Kwan-Hoong Ng. (2014) Therapeutic radionuclides in nuclear medicine: current and future prospects核医学放射性核素治疗的研究现状及前景. Journal of Zhejiang University SCIENCE B 15:10, pages 845-863.
Crossref
J. M. Fenger, C. A. London & W. C. Kisseberth. (2014) Canine Osteosarcoma: A Naturally Occurring Disease to Inform Pediatric Oncology. ILAR Journal 55:1, pages 69-85.
Crossref
Caroline Jochems, Jeffrey Schlom & James L. Gulley. 2014. Novel Technologies for Vaccine Development. Novel Technologies for Vaccine Development 291 327 .
Peter M. Anderson, Vivek Subbiah & Eric Rohren. 2014. Current Advances in Osteosarcoma. Current Advances in Osteosarcoma 291 304 .
Kosei Ando, Marie-Françoise Heymann, Verena Stresing, Kanji Mori, Françoise Rédini & Dominique Heymann. (2013) Current Therapeutic Strategies and Novel Approaches in Osteosarcoma. Cancers 5:4, pages 591-616.
Crossref
R. Alberto & H. Braband. 2013. Comprehensive Inorganic Chemistry II. Comprehensive Inorganic Chemistry II 785 817 .
Ravi A. Madan, Marijo Bilusic, Christopher Heery, Jeffrey Schlom & James L. Gulley. (2012) Clinical Evaluation of TRICOM Vector Therapeutic Cancer Vaccines. Seminars in Oncology 39:3, pages 296-304.
Crossref
Nathalie Gaspar, Angela Di Giannatale, Birgit Geoerger, Françoise Redini, Nadège Corradini, Natacha Enz-Werle, Franck Tirode, Perrine Marec-Berard, Jean-Claude Gentet, Valérie Laurence, Sophie Piperno-Neumann, Odile Oberlin & Laurence Brugieres. (2012) Bone Sarcomas: From Biology to Targeted Therapies. Sarcoma 2012, pages 1-18.
Crossref
Joanna Galezowska & Elzbieta Gumienna-Kontecka. (2012) Phosphonates, their complexes and bio-applications: A spectrum of surprising diversity. Coordination Chemistry Reviews 256:1-2, pages 105-124.
Crossref
Cecilia Larocca & Jeffrey Schlom. (2011) Viral Vector-Based Therapeutic Cancer Vaccines. The Cancer Journal 17:5, pages 359-371.
Crossref
Robert F. Hobbs, Todd McNutt, Sébastien Baechler, Bin He, Caroline E. Esaias, Eric C. Frey, David M. Loeb, Richard L. Wahl, Ori Shokek & George Sgouros. (2011) A Treatment Planning Method for Sequentially Combining Radiopharmaceutical Therapy and External Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics 80:4, pages 1256-1262.
Crossref
A. Bahrami-Samani, M. Ghannadi-Maragheh, A. R. Jalilian & M. Mazidi. (2010) Biological studies of samarium-153 bleomycin complex in human breast cancer murine xenografts for therapeutic applications. Radiochimica Acta 98:4.
Crossref
J. A. Lee, M. S. Kim, J.-S. Koh, M. S. Kim, D. H. Kim, J. S. Lim, C.-B. Kong, W. S. Song, W. H. Cho, S.-Y. Lee & D.-G. Jeon. (2009) Osteosarcoma of the Flat Bone. Japanese Journal of Clinical Oncology 40:1, pages 47-53.
Crossref
Eleanor Hendershot. 2010. Pediatric Oncology Nursing. Pediatric Oncology Nursing 59 127 .
Stephen S. Grubbs & Charles J. Schneider. 2009. Bone and Cancer. Bone and Cancer 219 227 .
Sara Lacerda, Fernanda Marques, Paula Campello, Lurdes Gano, Vojtěch Kubíček, Petr Hermann & Isabel Santos. (2009) Chemical, radiochemical and biological studies of Sm and Ho complexes of H4dota analogues containing one methylphosphonic/phosphinic acid pendant arm. Journal of Labelled Compounds and Radiopharmaceuticals 53:1, pages 36-43.
Crossref
B. Lortal, J. Caron, C. Dejean, F. Bonichon, N. Houédé, S. Buj & A.-L. Cazeau. (2009) Gestion du risque radioactif associé au décès d’un patient 12heures après injection de Quadramet®. Médecine Nucléaire 33:12, pages 754-757.
Crossref
David M. Loeb, Elizabeth Garrett‐Mayer, Robert F. Hobbs, Andrew R. Prideaux, George Sgouros, Ori Shokek, Moody D. WharamJrJr, Tammy Scott & Cindy L. Schwartz. (2009) Dose‐finding study of 153 Sm‐EDTMP in patients with poor‐prognosis osteosarcoma . Cancer 115:11, pages 2514-2522.
Crossref
Noah Federman, Nicholas Bernthal, Fritz C. Eilber & William D. Tap. (2009) The Multidisciplinary Management of Osteosarcoma. Current Treatment Options in Oncology 10:1-2, pages 82-93.
Crossref
Pete Anderson. 2010. Pediatric and Adolescent Osteosarcoma. Pediatric and Adolescent Osteosarcoma 203 215 .
Pete AndersonDavid KornguthKamran AhrarDennis HughesPhil PhanWinston HuhKathleen CorneliusAnita Mahajan. (2008) Recurrent, refractory, metastatic and/or unresectable pediatric sarcomas: treatment options for young people ‘off the roadmap’. Pediatric Health 2:5, pages 605-615.
Crossref
Stefan S. Bielack, Dorothe Carrle, Jendrik Hardes, Andreas Schuck & Michael Paulussen. (2008) Bone Tumors in Adolescents and Young Adults. Current Treatment Options in Oncology 9:1, pages 67-80.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.